RecruitingNCT05804331

The Australia and New Zealand Multicentre Upper Gastrointestinal Endoscopic Tissue Resection Study


Sponsor

Western Sydney Local Health District

Enrollment

500 participants

Start Date

Mar 14, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

To determine the long term outcomes of Endoscopic Submucosal Dissection (ESD), Endoscopic Full Thickness Resection (EFTR) and Submucosal-Tunnelling Endoscopic Resection (STER) for upper gastrointestinal neoplastic lesions


Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This multicenter Australian and New Zealand study is collecting data on outcomes of advanced endoscopic procedures — including endoscopic submucosal dissection (ESD), full-thickness resection (EFTR), and submucosal tunneling resection (STER) — used to remove tumors or abnormal growths in the upper digestive tract (esophagus, stomach, and duodenum). **You may be eligible if:** - You are 18 or older - You have a growth or lesion in the upper digestive tract (esophagus, stomach, or duodenum) larger than 10mm - The lesion is confined to the inner layers of the gut wall (suitable for one of the listed endoscopic procedures) **You may NOT be eligible if:** - You are under 18 - You are unable to give informed consent - You are pregnant or breastfeeding - You have a bleeding disorder or cannot safely stop blood-thinning medications before the procedure Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Westmead Hospital

Sydney, New South Wales, Australia

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05804331


Related Trials